Results 291 to 300 of about 640,298 (391)
Perioperative utilization of JAK inhibitors in Perianal Fistulizing Crohn's disease
Abstract With the recent approval of small molecule drugs such as upadacitinib in adult inflammatory bowel disease (IBD), their utilization is becoming more common; however, there is limited data on perioperative risks or optimal timing of cessation and resumption to mitigate flares. Current recommendations suggest holding these medications for 14 days
Alexander Lyons +2 more
wiley +1 more source
PLANT REMEDIES IN PREVENTIVE MAINTENANCE OF A STOMACH ULCER OF A STMACH AND A DUODENAL GUT
A. Ch. Tsyrempilova, S. V. Tsyrempilov
openalex +1 more source
Abstract Acute severe ulcerative colitis increases the risk for cytomegalovirus (CMV) infection, particularly with the use of immunocompromising medications. We report a case of a 4‐year‐old with newly diagnosed very early onset inflammatory bowel disease presenting with acute severe colitis refractory to both corticosteroids and infliximab, whose ...
Alison Laxer +3 more
wiley +1 more source
Emphysematous Gastritis Secondary to Embolic Infarction: A Case Report. [PDF]
Chung YC, Naqash N.
europepmc +1 more source
Abstract Primary eosinophilic gastrointestinal disorders beyond the esophagus (EGIDs) are rare, predominantly Th2‐mediated inflammatory conditions, affecting various segments of the gastrointestinal tract. We report the case of a 12‐year‐old boy with recurrent abdominal pain, peripheral eosinophilia, and progressive gastritis, duodenitis, and enteritis
Almudena Sánchez‐Ramírez +6 more
wiley +1 more source
Laparoscopically assisted distal gastrectomy with Billroth I anastomosis for refractory gastric outlet obstruction after endoscopic submucosal dissection procedure: a case report. [PDF]
Alexey S +6 more
europepmc +1 more source
Abstract Ustekinumab (UST) is a monoclonal antibody used in the management of moderate to severe inflammatory bowel disease. While generally well‐tolerated, serious adverse reactions, including hypersensitivity and anaphylaxis, have been documented, specifical following the initial intravenous (IV) dose.
Kennedy Sparling +2 more
wiley +1 more source
Development and evaluation of alginate-based gastroretentive raft-forming systems enabling sustained release of propolis in gastric ulcer treatment. [PDF]
Takbirgou H +7 more
europepmc +1 more source

